2021 Webinar: AASLD’s Thought Leaders Series: How I Manage My Practice-AASLD’s Thought Leaders Series: How I Manage My Practice

Video Transcription

Video Summary

The ASLD Thought Leader Series is a virtual session designed to provide clinical insights on liver conditions to a broad audience. In this session, the focus is on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The session is conducted as an interview with two experts in the field, Dr. Maru Ranella and Dr. Anna Mae Deal. The experts share their experiences and insights on managing their practices and conducting research on NAFLD and NASH. They discuss their career paths and what motivated them to work in the field of hepatology. They also discuss how they set up their NAFLD clinics and the importance of multidisciplinary care, including nutritionists and behavioral specialists. They touch on the use of genetic testing and omics-based testing in patient stratification, but also highlight the limitations of current knowledge in this area. They discuss the use of vitamin E as a treatment for NASH and the criteria they use for starting this treatment. Finally, they discuss the future of NAFLD and NASH treatment, highlighting the heterogeneity of the disease and the need for personalized medicine and combination therapies. They also discuss the challenges in assessing the effectiveness of new treatments and the potential role of genetic and biomarker testing in treatment decision-making. Overall, the session provides valuable insights into the management of NAFLD and NASH and the future of treatment options.

Keywords

ASLD Thought Leader Series

virtual session

liver conditions

NAFLD

NASH

experts

multidisciplinary care

treatment

genetic testing

personalized medicine